The study’s size, careful adjustment for confounding factors such as APOE ε4 status, and the novelty of linking IL12B to AD provide credibility, though the single-ethnicity design raises concerns about population specificity and functional validation remains lacking. The gene discussed is IL12B; the disease is Alzheimer disease.